Amicus Therapeutics Inc (FOLD)
9.63
-0.14
(-1.43%)
USD |
NASDAQ |
Dec 27, 16:00
9.635
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Total Long Term Debt (Quarterly): 389.49M for Sept. 30, 2024
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 7.992M |
| Immuneering Corp | -- |
| Halozyme Therapeutics Inc | 1.504B |
| Alnylam Pharmaceuticals Inc | 1.024B |
| Insmed Inc | 954.83M |